Global Continuous Subcutaneous Insulin Infusion Therapy Market Research Report 2024, Forecast to 2032

October 2024 | 125 pages | ID: G2D0C53B7DF0EN
Bosson Research

Abstracts

Report Overview

An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin infusion therapy. The device configuration may vary depending on design. A traditional pump includes: the pump (including controls, processing module, and batteries); a disposable reservoir for insulin (inside the pump) a disposable infusion set, including a cannula for subcutaneous insertion (under the skin) and a tubing system to interface the insulin reservoir to the cannula. Other configurations are possible. For instance, more recent models may include disposable or semi-disposable designs for the pumping mechanism and may eliminate tubing from the infusion set.

The global Continuous Subcutaneous Insulin Infusion Therapy market size was estimated at USD 714 million in 2023 and is projected to reach USD 1463.37 million by 2032, exhibiting a CAGR of 8.30% during the forecast period.

North America Continuous Subcutaneous Insulin Infusion Therapy market size was estimated at USD 213.46 million in 2023, at a CAGR of 7.11% during the forecast period of 2024 through 2032.

This report provides a deep insight into the global Continuous Subcutaneous Insulin Infusion Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Continuous Subcutaneous Insulin Infusion Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Continuous Subcutaneous Insulin Infusion Therapy market in any manner.

Global Continuous Subcutaneous Insulin Infusion Therapy Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Medtronic

Roche

SOOIL

Tandem Diabetes care

Insulet Corp

Valeritas

Microport

Market Segmentation (by Type)

Normal

Patch Pump

Market Segmentation (by Application)

Hospital

Retail Pharmacy

Other

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Continuous Subcutaneous Insulin Infusion Therapy Market
• Overview of the regional outlook of the Continuous Subcutaneous Insulin Infusion Therapy Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Continuous Subcutaneous Insulin Infusion Therapy Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Continuous Subcutaneous Insulin Infusion Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.

Chapter 13 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Continuous Subcutaneous Insulin Infusion Therapy
1.2 Key Market Segments
  1.2.1 Continuous Subcutaneous Insulin Infusion Therapy Segment by Type
  1.2.2 Continuous Subcutaneous Insulin Infusion Therapy Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 CONTINUOUS SUBCUTANEOUS INSULIN INFUSION THERAPY MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Continuous Subcutaneous Insulin Infusion Therapy Market Size (M USD) Estimates and Forecasts (2019-2032)
  2.1.2 Global Continuous Subcutaneous Insulin Infusion Therapy Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 CONTINUOUS SUBCUTANEOUS INSULIN INFUSION THERAPY MARKET COMPETITIVE LANDSCAPE

3.1 Global Continuous Subcutaneous Insulin Infusion Therapy Sales by Manufacturers (2019-2024)
3.2 Global Continuous Subcutaneous Insulin Infusion Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Continuous Subcutaneous Insulin Infusion Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Continuous Subcutaneous Insulin Infusion Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Continuous Subcutaneous Insulin Infusion Therapy Sales Sites, Area Served, Product Type
3.6 Continuous Subcutaneous Insulin Infusion Therapy Market Competitive Situation and Trends
  3.6.1 Continuous Subcutaneous Insulin Infusion Therapy Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Continuous Subcutaneous Insulin Infusion Therapy Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 CONTINUOUS SUBCUTANEOUS INSULIN INFUSION THERAPY INDUSTRY CHAIN ANALYSIS

4.1 Continuous Subcutaneous Insulin Infusion Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION THERAPY MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 CONTINUOUS SUBCUTANEOUS INSULIN INFUSION THERAPY MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Continuous Subcutaneous Insulin Infusion Therapy Sales Market Share by Type (2019-2024)
6.3 Global Continuous Subcutaneous Insulin Infusion Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Continuous Subcutaneous Insulin Infusion Therapy Price by Type (2019-2024)

7 CONTINUOUS SUBCUTANEOUS INSULIN INFUSION THERAPY MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Continuous Subcutaneous Insulin Infusion Therapy Market Sales by Application (2019-2024)
7.3 Global Continuous Subcutaneous Insulin Infusion Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Continuous Subcutaneous Insulin Infusion Therapy Sales Growth Rate by Application (2019-2024)

8 CONTINUOUS SUBCUTANEOUS INSULIN INFUSION THERAPY MARKET CONSUMPTION BY REGION

8.1 Global Continuous Subcutaneous Insulin Infusion Therapy Sales by Region
  8.1.1 Global Continuous Subcutaneous Insulin Infusion Therapy Sales by Region
  8.1.2 Global Continuous Subcutaneous Insulin Infusion Therapy Sales Market Share by Region
8.2 North America
  8.2.1 North America Continuous Subcutaneous Insulin Infusion Therapy Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Continuous Subcutaneous Insulin Infusion Therapy Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific Continuous Subcutaneous Insulin Infusion Therapy Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Continuous Subcutaneous Insulin Infusion Therapy Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Continuous Subcutaneous Insulin Infusion Therapy Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 CONTINUOUS SUBCUTANEOUS INSULIN INFUSION THERAPY MARKET PRODUCTION BY REGION

9.1 Global Production of Continuous Subcutaneous Insulin Infusion Therapy by Region (2019-2024)
9.2 Global Continuous Subcutaneous Insulin Infusion Therapy Revenue Market Share by Region (2019-2024)
9.3 Global Continuous Subcutaneous Insulin Infusion Therapy Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Continuous Subcutaneous Insulin Infusion Therapy Production
  9.4.1 North America Continuous Subcutaneous Insulin Infusion Therapy Production Growth Rate (2019-2024)
  9.4.2 North America Continuous Subcutaneous Insulin Infusion Therapy Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Continuous Subcutaneous Insulin Infusion Therapy Production
  9.5.1 Europe Continuous Subcutaneous Insulin Infusion Therapy Production Growth Rate (2019-2024)
  9.5.2 Europe Continuous Subcutaneous Insulin Infusion Therapy Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Continuous Subcutaneous Insulin Infusion Therapy Production (2019-2024)
  9.6.1 Japan Continuous Subcutaneous Insulin Infusion Therapy Production Growth Rate (2019-2024)
  9.6.2 Japan Continuous Subcutaneous Insulin Infusion Therapy Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Continuous Subcutaneous Insulin Infusion Therapy Production (2019-2024)
  9.7.1 China Continuous Subcutaneous Insulin Infusion Therapy Production Growth Rate (2019-2024)
  9.7.2 China Continuous Subcutaneous Insulin Infusion Therapy Production, Revenue, Price and Gross Margin (2019-2024)

10 KEY COMPANIES PROFILE

10.1 Medtronic
  10.1.1 Medtronic Continuous Subcutaneous Insulin Infusion Therapy Basic Information
  10.1.2 Medtronic Continuous Subcutaneous Insulin Infusion Therapy Product Overview
  10.1.3 Medtronic Continuous Subcutaneous Insulin Infusion Therapy Product Market Performance
  10.1.4 Medtronic Business Overview
  10.1.5 Medtronic Continuous Subcutaneous Insulin Infusion Therapy SWOT Analysis
  10.1.6 Medtronic Recent Developments
10.2 Roche
  10.2.1 Roche Continuous Subcutaneous Insulin Infusion Therapy Basic Information
  10.2.2 Roche Continuous Subcutaneous Insulin Infusion Therapy Product Overview
  10.2.3 Roche Continuous Subcutaneous Insulin Infusion Therapy Product Market Performance
  10.2.4 Roche Business Overview
  10.2.5 Roche Continuous Subcutaneous Insulin Infusion Therapy SWOT Analysis
  10.2.6 Roche Recent Developments
10.3 SOOIL
  10.3.1 SOOIL Continuous Subcutaneous Insulin Infusion Therapy Basic Information
  10.3.2 SOOIL Continuous Subcutaneous Insulin Infusion Therapy Product Overview
  10.3.3 SOOIL Continuous Subcutaneous Insulin Infusion Therapy Product Market Performance
  10.3.4 SOOIL Continuous Subcutaneous Insulin Infusion Therapy SWOT Analysis
  10.3.5 SOOIL Business Overview
  10.3.6 SOOIL Recent Developments
10.4 Tandem Diabetes care
  10.4.1 Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Therapy Basic Information
  10.4.2 Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Therapy Product Overview
  10.4.3 Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Therapy Product Market Performance
  10.4.4 Tandem Diabetes care Business Overview
  10.4.5 Tandem Diabetes care Recent Developments
10.5 Insulet Corp
  10.5.1 Insulet Corp Continuous Subcutaneous Insulin Infusion Therapy Basic Information
  10.5.2 Insulet Corp Continuous Subcutaneous Insulin Infusion Therapy Product Overview
  10.5.3 Insulet Corp Continuous Subcutaneous Insulin Infusion Therapy Product Market Performance
  10.5.4 Insulet Corp Business Overview
  10.5.5 Insulet Corp Recent Developments
10.6 Valeritas
  10.6.1 Valeritas Continuous Subcutaneous Insulin Infusion Therapy Basic Information
  10.6.2 Valeritas Continuous Subcutaneous Insulin Infusion Therapy Product Overview
  10.6.3 Valeritas Continuous Subcutaneous Insulin Infusion Therapy Product Market Performance
  10.6.4 Valeritas Business Overview
  10.6.5 Valeritas Recent Developments
10.7 Microport
  10.7.1 Microport Continuous Subcutaneous Insulin Infusion Therapy Basic Information
  10.7.2 Microport Continuous Subcutaneous Insulin Infusion Therapy Product Overview
  10.7.3 Microport Continuous Subcutaneous Insulin Infusion Therapy Product Market Performance
  10.7.4 Microport Business Overview
  10.7.5 Microport Recent Developments

11 CONTINUOUS SUBCUTANEOUS INSULIN INFUSION THERAPY MARKET FORECAST BY REGION

11.1 Global Continuous Subcutaneous Insulin Infusion Therapy Market Size Forecast
11.2 Global Continuous Subcutaneous Insulin Infusion Therapy Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Continuous Subcutaneous Insulin Infusion Therapy Market Size Forecast by Country
  11.2.3 Asia Pacific Continuous Subcutaneous Insulin Infusion Therapy Market Size Forecast by Region
  11.2.4 South America Continuous Subcutaneous Insulin Infusion Therapy Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Consumption of Continuous Subcutaneous Insulin Infusion Therapy by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)

12.1 Global Continuous Subcutaneous Insulin Infusion Therapy Market Forecast by Type (2025-2032)
  12.1.1 Global Forecasted Sales of Continuous Subcutaneous Insulin Infusion Therapy by Type (2025-2032)
  12.1.2 Global Continuous Subcutaneous Insulin Infusion Therapy Market Size Forecast by Type (2025-2032)
  12.1.3 Global Forecasted Price of Continuous Subcutaneous Insulin Infusion Therapy by Type (2025-2032)
12.2 Global Continuous Subcutaneous Insulin Infusion Therapy Market Forecast by Application (2025-2032)
  12.2.1 Global Continuous Subcutaneous Insulin Infusion Therapy Sales (K Units) Forecast by Application
  12.2.2 Global Continuous Subcutaneous Insulin Infusion Therapy Market Size (M USD) Forecast by Application (2025-2032)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Continuous Subcutaneous Insulin Infusion Therapy Market Size Comparison by Region (M USD)
Table 5. Global Continuous Subcutaneous Insulin Infusion Therapy Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Continuous Subcutaneous Insulin Infusion Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Continuous Subcutaneous Insulin Infusion Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Continuous Subcutaneous Insulin Infusion Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Continuous Subcutaneous Insulin Infusion Therapy as of 2022)
Table 10. Global Market Continuous Subcutaneous Insulin Infusion Therapy Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Continuous Subcutaneous Insulin Infusion Therapy Sales Sites and Area Served
Table 12. Manufacturers Continuous Subcutaneous Insulin Infusion Therapy Product Type
Table 13. Global Continuous Subcutaneous Insulin Infusion Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Continuous Subcutaneous Insulin Infusion Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Continuous Subcutaneous Insulin Infusion Therapy Market Challenges
Table 22. Global Continuous Subcutaneous Insulin Infusion Therapy Sales by Type (K Units)
Table 23. Global Continuous Subcutaneous Insulin Infusion Therapy Market Size by Type (M USD)
Table 24. Global Continuous Subcutaneous Insulin Infusion Therapy Sales (K Units) by Type (2019-2024)
Table 25. Global Continuous Subcutaneous Insulin Infusion Therapy Sales Market Share by Type (2019-2024)
Table 26. Global Continuous Subcutaneous Insulin Infusion Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Continuous Subcutaneous Insulin Infusion Therapy Market Size Share by Type (2019-2024)
Table 28. Global Continuous Subcutaneous Insulin Infusion Therapy Price (USD/Unit) by Type (2019-2024)
Table 29. Global Continuous Subcutaneous Insulin Infusion Therapy Sales (K Units) by Application
Table 30. Global Continuous Subcutaneous Insulin Infusion Therapy Market Size by Application
Table 31. Global Continuous Subcutaneous Insulin Infusion Therapy Sales by Application (2019-2024) & (K Units)
Table 32. Global Continuous Subcutaneous Insulin Infusion Therapy Sales Market Share by Application (2019-2024)
Table 33. Global Continuous Subcutaneous Insulin Infusion Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Continuous Subcutaneous Insulin Infusion Therapy Market Share by Application (2019-2024)
Table 35. Global Continuous Subcutaneous Insulin Infusion Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Continuous Subcutaneous Insulin Infusion Therapy Sales by Region (2019-2024) & (K Units)
Table 37. Global Continuous Subcutaneous Insulin Infusion Therapy Sales Market Share by Region (2019-2024)
Table 38. North America Continuous Subcutaneous Insulin Infusion Therapy Sales by Country (2019-2024) & (K Units)
Table 39. Europe Continuous Subcutaneous Insulin Infusion Therapy Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Continuous Subcutaneous Insulin Infusion Therapy Sales by Region (2019-2024) & (K Units)
Table 41. South America Continuous Subcutaneous Insulin Infusion Therapy Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Continuous Subcutaneous Insulin Infusion Therapy Sales by Region (2019-2024) & (K Units)
Table 43. Global Continuous Subcutaneous Insulin Infusion Therapy Production (K Units) by Region (2019-2024)
Table 44. Global Continuous Subcutaneous Insulin Infusion Therapy Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Continuous Subcutaneous Insulin Infusion Therapy Revenue Market Share by Region (2019-2024)
Table 46. Global Continuous Subcutaneous Insulin Infusion Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 47. North America Continuous Subcutaneous Insulin Infusion Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 48. Europe Continuous Subcutaneous Insulin Infusion Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 49. Japan Continuous Subcutaneous Insulin Infusion Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 50. China Continuous Subcutaneous Insulin Infusion Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 51. Medtronic Continuous Subcutaneous Insulin Infusion Therapy Basic Information
Table 52. Medtronic Continuous Subcutaneous Insulin Infusion Therapy Product Overview
Table 53. Medtronic Continuous Subcutaneous Insulin Infusion Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 54. Medtronic Business Overview
Table 55. Medtronic Continuous Subcutaneous Insulin Infusion Therapy SWOT Analysis
Table 56. Medtronic Recent Developments
Table 57. Roche Continuous Subcutaneous Insulin Infusion Therapy Basic Information
Table 58. Roche Continuous Subcutaneous Insulin Infusion Therapy Product Overview
Table 59. Roche Continuous Subcutaneous Insulin Infusion Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Roche Business Overview
Table 61. Roche Continuous Subcutaneous Insulin Infusion Therapy SWOT Analysis
Table 62. Roche Recent Developments
Table 63. SOOIL Continuous Subcutaneous Insulin Infusion Therapy Basic Information
Table 64. SOOIL Continuous Subcutaneous Insulin Infusion Therapy Product Overview
Table 65. SOOIL Continuous Subcutaneous Insulin Infusion Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 66. SOOIL Continuous Subcutaneous Insulin Infusion Therapy SWOT Analysis
Table 67. SOOIL Business Overview
Table 68. SOOIL Recent Developments
Table 69. Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Therapy Basic Information
Table 70. Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Therapy Product Overview
Table 71. Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 72. Tandem Diabetes care Business Overview
Table 73. Tandem Diabetes care Recent Developments
Table 74. Insulet Corp Continuous Subcutaneous Insulin Infusion Therapy Basic Information
Table 75. Insulet Corp Continuous Subcutaneous Insulin Infusion Therapy Product Overview
Table 76. Insulet Corp Continuous Subcutaneous Insulin Infusion Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 77. Insulet Corp Business Overview
Table 78. Insulet Corp Recent Developments
Table 79. Valeritas Continuous Subcutaneous Insulin Infusion Therapy Basic Information
Table 80. Valeritas Continuous Subcutaneous Insulin Infusion Therapy Product Overview
Table 81. Valeritas Continuous Subcutaneous Insulin Infusion Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Valeritas Business Overview
Table 83. Valeritas Recent Developments
Table 84. Microport Continuous Subcutaneous Insulin Infusion Therapy Basic Information
Table 85. Microport Continuous Subcutaneous Insulin Infusion Therapy Product Overview
Table 86. Microport Continuous Subcutaneous Insulin Infusion Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Microport Business Overview
Table 88. Microport Recent Developments
Table 89. Global Continuous Subcutaneous Insulin Infusion Therapy Sales Forecast by Region (2025-2032) & (K Units)
Table 90. Global Continuous Subcutaneous Insulin Infusion Therapy Market Size Forecast by Region (2025-2032) & (M USD)
Table 91. North America Continuous Subcutaneous Insulin Infusion Therapy Sales Forecast by Country (2025-2032) & (K Units)
Table 92. North America Continuous Subcutaneous Insulin Infusion Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 93. Europe Continuous Subcutaneous Insulin Infusion Therapy Sales Forecast by Country (2025-2032) & (K Units)
Table 94. Europe Continuous Subcutaneous Insulin Infusion Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 95. Asia Pacific Continuous Subcutaneous Insulin Infusion Therapy Sales Forecast by Region (2025-2032) & (K Units)
Table 96. Asia Pacific Continuous Subcutaneous Insulin Infusion Therapy Market Size Forecast by Region (2025-2032) & (M USD)
Table 97. South America Continuous Subcutaneous Insulin Infusion Therapy Sales Forecast by Country (2025-2032) & (K Units)
Table 98. South America Continuous Subcutaneous Insulin Infusion Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 99. Middle East and Africa Continuous Subcutaneous Insulin Infusion Therapy Consumption Forecast by Country (2025-2032) & (Units)
Table 100. Middle East and Africa Continuous Subcutaneous Insulin Infusion Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 101. Global Continuous Subcutaneous Insulin Infusion Therapy Sales Forecast by Type (2025-2032) & (K Units)
Table 102. Global Continuous Subcutaneous Insulin Infusion Therapy Market Size Forecast by Type (2025-2032) & (M USD)
Table 103. Global Continuous Subcutaneous Insulin Infusion Therapy Price Forecast by Type (2025-2032) & (USD/Unit)
Table 104. Global Continuous Subcutaneous Insulin Infusion Therapy Sales (K Units) Forecast by Application (2025-2032)
Table 105. Global Continuous Subcutaneous Insulin Infusion Therapy Market Size Forecast by Application (2025-2032) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Continuous Subcutaneous Insulin Infusion Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Continuous Subcutaneous Insulin Infusion Therapy Market Size (M USD), 2019-2032
Figure 5. Global Continuous Subcutaneous Insulin Infusion Therapy Market Size (M USD) (2019-2032)
Figure 6. Global Continuous Subcutaneous Insulin Infusion Therapy Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Continuous Subcutaneous Insulin Infusion Therapy Market Size by Country (M USD)
Figure 11. Continuous Subcutaneous Insulin Infusion Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Continuous Subcutaneous Insulin Infusion Therapy Revenue Share by Manufacturers in 2023
Figure 13. Continuous Subcutaneous Insulin Infusion Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Continuous Subcutaneous Insulin Infusion Therapy Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Continuous Subcutaneous Insulin Infusion Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Continuous Subcutaneous Insulin Infusion Therapy Market Share by Type
Figure 18. Sales Market Share of Continuous Subcutaneous Insulin Infusion Therapy by Type (2019-2024)
Figure 19. Sales Market Share of Continuous Subcutaneous Insulin Infusion Therapy by Type in 2023
Figure 20. Market Size Share of Continuous Subcutaneous Insulin Infusion Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of Continuous Subcutaneous Insulin Infusion Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Continuous Subcutaneous Insulin Infusion Therapy Market Share by Application
Figure 24. Global Continuous Subcutaneous Insulin Infusion Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global Continuous Subcutaneous Insulin Infusion Therapy Sales Market Share by Application in 2023
Figure 26. Global Continuous Subcutaneous Insulin Infusion Therapy Market Share by Application (2019-2024)
Figure 27. Global Continuous Subcutaneous Insulin Infusion Therapy Market Share by Application in 2023
Figure 28. Global Continuous Subcutaneous Insulin Infusion Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Continuous Subcutaneous Insulin Infusion Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America Continuous Subcutaneous Insulin Infusion Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Continuous Subcutaneous Insulin Infusion Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Continuous Subcutaneous Insulin Infusion Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Continuous Subcutaneous Insulin Infusion Therapy Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Continuous Subcutaneous Insulin Infusion Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Continuous Subcutaneous Insulin Infusion Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Continuous Subcutaneous Insulin Infusion Therapy Sales Market Share by Country in 2023
Figure 37. Germany Continuous Subcutaneous Insulin Infusion Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Continuous Subcutaneous Insulin Infusion Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Continuous Subcutaneous Insulin Infusion Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Continuous Subcutaneous Insulin Infusion Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Continuous Subcutaneous Insulin Infusion Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Continuous Subcutaneous Insulin Infusion Therapy Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Continuous Subcutaneous Insulin Infusion Therapy Sales Market Share by Region in 2023
Figure 44. China Continuous Subcutaneous Insulin Infusion Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Continuous Subcutaneous Insulin Infusion Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Continuous Subcutaneous Insulin Infusion Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Continuous Subcutaneous Insulin Infusion Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Continuous Subcutaneous Insulin Infusion Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Continuous Subcutaneous Insulin Infusion Therapy Sales and Growth Rate (K Units)
Figure 50. South America Continuous Subcutaneous Insulin Infusion Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Continuous Subcutaneous Insulin Infusion Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Continuous Subcutaneous Insulin Infusion Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Continuous Subcutaneous Insulin Infusion Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Continuous Subcutaneous Insulin Infusion Therapy Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Continuous Subcutaneous Insulin Infusion Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Continuous Subcutaneous Insulin Infusion Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Continuous Subcutaneous Insulin Infusion Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Continuous Subcutaneous Insulin Infusion Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Continuous Subcutaneous Insulin Infusion Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Continuous Subcutaneous Insulin Infusion Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Continuous Subcutaneous Insulin Infusion Therapy Production Market Share by Region (2019-2024)
Figure 62. North America Continuous Subcutaneous Insulin Infusion Therapy Production (K Units) Growth Rate (2019-2024)
Figure 63. Europe Continuous Subcutaneous Insulin Infusion Therapy Production (K Units) Growth Rate (2019-2024)
Figure 64. Japan Continuous Subcutaneous Insulin Infusion Therapy Production (K Units) Growth Rate (2019-2024)
Figure 65. China Continuous Subcutaneous Insulin Infusion Therapy Production (K Units) Growth Rate (2019-2024)
Figure 66. Global Continuous Subcutaneous Insulin Infusion Therapy Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Continuous Subcutaneous Insulin Infusion Therapy Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Continuous Subcutaneous Insulin Infusion Therapy Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Continuous Subcutaneous Insulin Infusion Therapy Market Share Forecast by Type (2025-2032)
Figure 70. Global Continuous Subcutaneous Insulin Infusion Therapy Sales Forecast by Application (2025-2032)
Figure 71. Global Continuous Subcutaneous Insulin Infusion Therapy Market Share Forecast by Application (2025-2032)